+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bio-implant Market - Global Forecast 2026-2032- Product Image
Bio-implant Market - Global Forecast 2026-2032- Product Image
Sale

Bio-implant Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083152
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bio-implant Market is projected to reach USD 152.79 Billion in 2026. It is expected to continue growing at a CAGR of 7.99%, reaching USD 245.32 Billion by 2032.

Bio-implants are moving from device-centric products to data-informed therapeutic platforms used across orthopedics, cardiovascular care, dental reconstruction, ophthalmology, neuromodulation, and tissue repair. Demand is structurally supported by aging populations, chronic disease prevalence, and improved surgical access. The World Health Organization reports that cardiovascular diseases remain the world’s leading cause of death, while oral diseases affect an estimated 3.5 billion people globally, reinforcing long-term need for cardiovascular, dental, and reconstructive bio-implant solutions.

The bio-implant market is also being shaped by advances in biocompatible materials, 3D printing, regenerative medicine, minimally invasive surgery, and connected post-operative monitoring. Hospitals, ambulatory surgical centers, and specialty clinics increasingly evaluate implants not only by clinical performance but also by durability, infection risk, reimbursement fit, supply reliability, and evidence generated through real-world data.

Transformative Shifts in the Bio-Implant Landscape

The competitive landscape is shifting toward personalized, biologically integrated, and digitally enabled implants. Additive manufacturing enables patient-specific orthopedic and cranio-maxillofacial implants, while surface engineering, antimicrobial coatings, and bioresorbable materials are improving osseointegration and reducing complication risk. Regulatory bodies such as the U.S. FDA and European authorities continue to emphasize clinical evidence, post-market surveillance, and device traceability, increasing the importance of quality systems and lifecycle data.

Healthcare systems are also prioritizing value-based purchasing. Implant manufacturers must demonstrate measurable improvements in patient outcomes, revision rates, operating-room efficiency, and total cost of care. This is encouraging partnerships among medtech companies, material science firms, AI developers, contract manufacturers, and healthcare providers to accelerate innovation while strengthening supply chain resilience.

Cumulative Impact of Artificial Intelligence on Bio-Implants

Artificial intelligence is becoming a practical accelerator across the bio-implant value chain. In research and development, AI models support material selection, finite element analysis, implant design optimization, and faster screening of biocompatibility risks. In clinical planning, AI-assisted imaging can help surgeons evaluate bone quality, anatomical alignment, and implant sizing, especially in orthopedic, dental, and spinal procedures.

The cumulative impact of AI is strongest when combined with real-world evidence and connected care. Predictive analytics can identify patients at higher risk of implant failure, infection, or readmission, enabling earlier intervention. For manufacturers, AI improves demand planning, quality inspection, adverse event signal detection, and regulatory documentation workflows. However, AI adoption must remain aligned with clinical validation, cybersecurity, patient privacy, and transparent model governance.

Key Regional Insights for Bio-Implants

North America remains a leading bio-implant market due to advanced hospital infrastructure, high procedure volumes, established reimbursement pathways, and strong medtech innovation in the United States and Canada. Demand is reinforced by chronic disease burden, sports injuries, dental restoration needs, and an aging population requiring orthopedic, cardiovascular, ophthalmic, and neuromodulation implants. Public health data showing sustained cardiovascular disease burden and musculoskeletal procedure demand continue to support adoption of clinically proven implantable solutions.

Europe benefits from mature healthcare systems, strong regulatory oversight, and a large base of orthopedic, dental, and cardiovascular device capabilities. The European Union’s Medical Device Regulation has increased evidence requirements, which favors organizations with robust clinical data, quality management systems, traceability, and post-market surveillance capabilities. Asia-Pacific is a fast-developing opportunity area, supported by expanding healthcare access, medical tourism, rising middle-class spending, and large patient populations in China, India, Japan, South Korea, ASEAN economies, and Australia.

Latin America shows steady demand led by Brazil and Mexico, where private healthcare investment, dental implant adoption, and access to specialist surgery are improving. The Middle East is investing in specialty hospitals, medical tourism, and advanced surgical capabilities, particularly across GCC economies where healthcare modernization programs emphasize high-acuity care. Africa remains comparatively underpenetrated, but long-term prospects are supported by urbanization, gradual healthcare infrastructure investment, and rising demand for trauma, dental, orthopedic, and reconstructive care.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is gaining relevance as a bio-implant growth corridor due to expanding private hospitals, rising dental tourism, and improving access to orthopedic and cardiovascular procedures in markets such as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is building advanced medical hubs through national healthcare transformation programs, supporting demand for premium implants, robotic surgery, internationally accredited specialty care, and imported as well as locally supported medical technologies.

The European Union remains a critical regulatory and commercial bloc where compliance with MDR, clinical evidence generation, medical device traceability, and sustainability expectations influence market entry and portfolio strategy. BRICS economies are important for volume expansion because Brazil, Russia, India, China, and South Africa combine large patient populations with increasing domestic manufacturing capabilities, public procurement reforms, and cost-sensitive healthcare environments.

G7 countries represent high-value demand for advanced bio-implants, including smart orthopedic systems, dental implants, neurostimulation devices, ophthalmic implants, and next-generation cardiovascular implants. NATO members overlap significantly with major regulated healthcare markets, where supply security, medical technology resilience, cybersecurity, and trusted manufacturing networks are becoming more strategically important for implantable medical devices.

Key Country Insights for Bio-Implant Growth

The United States is the most influential country market, driven by strong FDA-regulated innovation, high adoption of advanced surgical technologies, and significant demand for orthopedic, cardiovascular, dental, ophthalmic, and neurostimulation implants. Canada benefits from universal healthcare coverage and a mature specialist network, while Mexico combines domestic demand with medical tourism and nearshoring potential. Brazil is Latin America’s largest healthcare market and is important for dental, orthopedic, cardiovascular, and reconstructive implants.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show sustained demand due to aging populations, established surgical capacity, and strong clinical standards. Germany is particularly important for engineering, precision manufacturing, and orthopedic innovation, while France, Italy, and Spain support broad uptake across public and private healthcare channels. Russia remains a complex market due to procurement localization, import substitution policies, regulatory requirements, and geopolitical constraints affecting medical technology access.

China and India offer substantial long-term expansion due to large patient populations, rising procedure volumes, broader insurance coverage, and increasing domestic production of implantable medical devices. Japan and South Korea are advanced markets with strong adoption of precision medical technologies, aging-related orthopedic and dental needs, and high-quality hospital systems. Australia maintains stable demand supported by an aging population, strong regulatory standards, trauma care capacity, and advanced orthopedic and dental care access.

Actionable Recommendations for Bio-Implant Industry Leaders

Industry leaders should prioritize clinically differentiated products that reduce revision risk, support faster recovery, and demonstrate measurable health-economic value. Investment in biocompatible materials, antimicrobial surfaces, patient-specific implants, minimally invasive delivery systems, connected monitoring, and AI-supported surgical planning can improve competitiveness in both premium and cost-sensitive markets.

Organizations should also strengthen regulatory intelligence, post-market surveillance, adverse event monitoring, and real-world evidence programs to meet rising expectations from regulators, payers, surgeons, and hospital procurement teams. Strategic localization in Asia-Pacific, Latin America, and the Middle East can improve affordability and market access, while resilient supplier networks, qualified alternate materials, and dual-source manufacturing can reduce disruption risk.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified public sources, including global health agencies, regulatory authorities, healthcare policy publications, peer-reviewed literature, clinical guidance, public procurement information, and recognized industry databases. Core indicators include disease burden, population aging, surgical adoption, regulatory change, reimbursement dynamics, healthcare infrastructure, and medical technology innovation.

Insights are triangulated across regional healthcare infrastructure, implant category adoption, regulatory frameworks, competitive activity, and macroeconomic indicators. Qualitative interpretation emphasizes data-backed trends rather than unsupported projections, ensuring the analysis remains suitable for executive decision-making.

Conclusion

The bio-implant industry is entering a period of higher clinical, regulatory, and technological expectations. Growth drivers include aging demographics, chronic disease prevalence, rising surgical access, trauma and dental care needs, and demand for durable, patient-specific solutions. At the same time, success increasingly depends on evidence quality, affordability, supply chain resilience, regulatory readiness, and digital integration.

Manufacturers that combine biomaterials expertise, AI-enabled design, real-world evidence, and regional market adaptation will be best positioned to address opportunities across established and emerging markets. The next phase of bio-implant competition will reward organizations that deliver safer implants, better outcomes, lower complication risk, and stronger value across the full patient care pathway.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bio-implant Market, by Product Type
7.1. Introduction
7.2. Cardiovascular Implants
7.2.1. Artificial Heart Valves
7.2.2. Pacemakers
7.2.3. Stents
7.2.4. Vascular Grafts
7.3. Dental Implants
7.3.1. Endosseous Implants
7.3.2. Subperiosteal Implants
7.3.3. Transosteal Implants
7.4. Neurological Implants
7.4.1. Deep Brain Stimulators
7.4.2. Neuroprosthetics
7.4.3. Spinal Cord Stimulators
7.5. Ophthalmic Implants
7.5.1. Corneal Implants
7.5.2. Intraocular Lenses
7.5.3. Retinal Implants
7.6. Orthopedic Implants
7.6.1. Hip Implants
7.6.1.1. Hip Resurfacing
7.6.1.2. Total Hip Replacement
7.6.2. Knee Implants
7.6.2.1. Partial Knee Replacement
7.6.2.2. Total Knee Replacement
7.6.3. Shoulder Implants
7.6.4. Spinal Implants
8. Bio-implant Market, by Material
8.1. Introduction
8.2. Ceramic
8.3. Composite
8.4. Polymer
8.4.1. Biodegradable Polymers
8.4.2. Uhmwpe
8.5. Titanium
9. Bio-implant Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Clinics
9.4. Hospitals
9.5. Research Institutes
10. Bio-implant Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Bio-implant Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Bio-implant Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Bio-implant Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AAP Implantate AG
15.2. Abbott Laboratories
15.3. Align Technology Inc
15.4. Alphatec Holdings Inc
15.5. Alphatec Spine Inc
15.6. Arthrex Inc
15.7. BioHorizons Inc
15.8. Biotronik SE & Co KG
15.9. Boston Scientific Corporation
15.10. Cochlear Limited
15.11. CONMED Corporation
15.12. Dentium Co Ltd
15.13. Dentsply Sirona Inc
15.14. Envista Holdings Corporation
15.15. Exactech Inc
15.16. Globus Medical Inc
15.17. Heraeus Medical GmbH
15.18. Integra LifeSciences Holdings Corporation
15.19. Johnson & Johnson
15.20. Medtronic plc
15.21. MegaGen Implant Co Ltd
15.22. MiMedx Group Inc
15.23. Organogenesis Holdings Inc
15.24. Osstem Implant Co Ltd
15.25. SINTX Technologies Inc
15.26. Smith & Nephew PLC
15.27. Straumann Holding AG
15.28. Stryker Corporation
15.29. Zimmer Biomet Holdings Inc
List of Figures
FIGURE 1. GLOBAL BIO-IMPLANT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIO-IMPLANT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIO-IMPLANT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIO-IMPLANT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIO-IMPLANT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIO-IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL BIO-IMPLANT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIO-IMPLANT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIO-IMPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PACEMAKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PACEMAKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PACEMAKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ENDOSSEOUS IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ENDOSSEOUS IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ENDOSSEOUS IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SUBPERIOSTEAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SUBPERIOSTEAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SUBPERIOSTEAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL TRANSOSTEAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL TRANSOSTEAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL TRANSOSTEAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL NEUROLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL NEUROLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL NEUROLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL NEUROPROSTHETICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL NEUROPROSTHETICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL NEUROPROSTHETICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL OPHTHALMIC IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL OPHTHALMIC IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL OPHTHALMIC IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CORNEAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CORNEAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CORNEAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL INTRAOCULAR LENSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INTRAOCULAR LENSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INTRAOCULAR LENSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL RETINAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL RETINAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL RETINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HIP IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL HIP IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HIP IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HIP RESURFACING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HIP RESURFACING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HIP RESURFACING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TOTAL HIP REPLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL TOTAL HIP REPLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TOTAL HIP REPLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL KNEE IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL KNEE IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL KNEE IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PARTIAL KNEE REPLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PARTIAL KNEE REPLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PARTIAL KNEE REPLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL TOTAL KNEE REPLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL TOTAL KNEE REPLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TOTAL KNEE REPLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SHOULDER IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SHOULDER IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SHOULDER IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SPINAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SPINAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CERAMIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL CERAMIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CERAMIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL COMPOSITE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL COMPOSITE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL COMPOSITE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL POLYMER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL POLYMER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL POLYMER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL UHMWPE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL UHMWPE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL UHMWPE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 161. EUROPE BIO-IMPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. EUROPE BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. EUROPE BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 164. EUROPE BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 165. EUROPE BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 166. EUROPE BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 167. EUROPE BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 168. EUROPE BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 169. EUROPE BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 170. EUROPE BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 171. EUROPE BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 172. EUROPE BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. EUROPE BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 187. AFRICA BIO-IMPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 188. AFRICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 189. AFRICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 190. AFRICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 191. AFRICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 192. AFRICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 193. AFRICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 194. AFRICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 195. AFRICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 196. AFRICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 197. AFRICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 198. AFRICA BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. AFRICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 200. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 201. ASEAN BIO-IMPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 202. ASEAN BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 203. ASEAN BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 204. ASEAN BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 205. ASEAN BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 206. ASEAN BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 207. ASEAN BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 208. ASEAN BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 209. ASEAN BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 210. ASEAN BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 211. ASEAN BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 212. ASEAN BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. ASEAN BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 214. GCC BIO-IMPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. GCC BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 216. GCC BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 217. GCC BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 218. GCC BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 219. GCC BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 220. GCC BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 221. GCC BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 222. GCC BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 223. GCC BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 224. GCC BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 225. GCC BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 226. GCC BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 240. BRICS BIO-IMPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 241. BRICS BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 242. BRICS BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 243. BRICS BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 244. BRICS BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 245. BRICS BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 246. BRICS BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 247. BRICS BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 248. BRICS BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 249. BRICS BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 250. BRICS BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 251. BRICS BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. BRICS BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 253. G7 BIO-IMPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 254. G7 BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 255. G7 BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 256. G7 BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 257. G7 BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 258. G7 BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 259. G7 BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 260. G7 BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 261. G7 BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 262. G7 BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 263. G7 BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 264. G7 BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. G7 BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 266. NATO BIO-IMPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 267. NATO BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. NATO BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 269. NATO BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 270. NATO BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 271. NATO BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 272. NATO BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 273. NATO BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 274. NATO BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 275. NATO BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 276. NATO BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 277. NATO BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. NATO BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 279. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES BIO-IMPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 293. CANADA BIO-IMPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. CANADA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 295. CANADA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 296. CANADA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 297. CANADA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 298. CANADA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 299. CANADA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 300. CANADA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 301. CANADA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 302. CANADA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 303. CANADA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 304. CANADA BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. CANADA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 306. MEXICO BIO-IMPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. MEXICO BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 308. MEXICO BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 309. MEXICO BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 310. MEXICO BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 311. MEXICO BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 312. MEXICO BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 313. MEXICO BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 314. MEXICO BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 315. MEXICO BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 316. MEXICO BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 317. MEXICO BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. MEXICO BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 319. BRAZIL BIO-IMPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. BRAZIL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 321. BRAZIL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 322. BRAZIL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 323. BRAZIL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 324. BRAZIL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 325. BRAZIL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 326. BRAZIL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 327. BRAZIL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 328. BRAZIL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 329. BRAZIL BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 330. BRAZIL BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 331. BRAZIL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 332. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 333. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 334. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 335. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 336. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 342. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 343. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 344. UNITED KINGDOM BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 345. GERMANY BIO-IMPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 346. GERMANY BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 347. GERMANY BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 348. GERMANY BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 349. GERMANY BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 350. GERMANY BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 351. GERMANY BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 352. GERMANY BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 353. GERMANY BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 354. GERMANY BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 355. GERMANY BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 356. GERMANY BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 357. GERMANY BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 358. FRANCE BIO-IMPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 359. FRANCE BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 360. FRANCE BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 361. FRANCE BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 362. FRANCE BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 363. FRANCE BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 364. FRANCE BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 365. FRANCE BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 366. FRANCE BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 367. FRANCE BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 368. FRANCE BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 369. FRANCE BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 370. FRANCE BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 371. RUSSIA BIO-IMPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 372. RUSSIA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 373. RUSSIA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2017-2032 (USD MILLION)
TABLE 374. RUSSIA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 375. RUSSIA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 376. RUSSIA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 377. RUSSIA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 378. RUSSIA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2017-2032 (USD MILLION)
TABLE 379. RUSSIA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2017-2032 (USD MILLION)
TABLE 380. RUSSIA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 381. RUSSIA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2017-2032 (USD MILLION)
TABLE 382. RUSSIA BIO-IMPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 383. RUSSIA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CH

Companies Mentioned

  • AAP Implantate AG
  • Abbott Laboratories
  • Align Technology Inc
  • Alphatec Holdings Inc
  • Alphatec Spine Inc
  • Arthrex Inc
  • BioHorizons Inc
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Cochlear Limited
  • CONMED Corporation
  • Dentium Co Ltd
  • Dentsply Sirona Inc
  • Envista Holdings Corporation
  • Exactech Inc
  • Globus Medical Inc
  • Heraeus Medical GmbH
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MegaGen Implant Co Ltd
  • MiMedx Group Inc
  • Organogenesis Holdings Inc
  • Osstem Implant Co Ltd
  • SINTX Technologies Inc
  • Smith & Nephew PLC
  • Straumann Holding AG
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 152.79 Billion
Forecasted Market Value ( USD ) by 2032 $ 245.32 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Synthetic Bio-implants Market - Global Forecast 2026-2032 - Product Image

Synthetic Bio-implants Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Biological Implants Market - Global Forecast 2026-2032 - Product Image

Biological Implants Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Bio-Implants Market Size, Share, Trends and Forecast by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region, 2026-2034 - Product Image

Bio-Implants Market Size, Share, Trends and Forecast by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region, 2026-2034

  • Report
  • 139 Pages
  • Global
From
Bio-Implants Market - Product Image

Bio-Implants Market

  • Report
  • 150 Pages
  • Global
From
Bio-Implants Market Report 2026 - Product Image

Bio-Implants Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Market

Bioimplant is a type of biomaterial used in medical applications. It is a device that is implanted into the body to replace or support a biological structure or function. Bioimplants are typically made from biocompatible materials such as metals, ceramics, polymers, and composites. These materials are designed to be compatible with the body and to provide a safe and effective solution for medical applications. Bioimplants are used in a variety of medical applications, including orthopedic, cardiovascular, dental, and ophthalmic. They are also used in the treatment of cancer, neurological disorders, and other medical conditions. Bioimplants are designed to be durable and to provide long-term performance. The bioimplant market is growing rapidly due to the increasing demand for medical devices and the development of new technologies. The market is expected to continue to grow in the coming years as more medical applications are developed and new materials are developed. Some of the major companies in the bioimplant market include Johnson & Johnson, Zimmer Biomet, Stryker, Medtronic, and Smith & Nephew. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.